High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome

被引：92

作者：

Chamuleau, Martine E. D. ^{[1
]}

de Loosdrecht, Arjan A. van ^{[1
]}

Hess, Corine J. ^{[1
]}

Janssen, Jeroen I. W. M. ^{[1
]}

Zevenbergen, Adri ^{[1
]}

Delwel, Ruud ^{[2
]}

Valk, Peter J. M. ^{[2
]}

Loewenberg, Bob ^{[2
]}

Ossenkoppele, Gert J. ^{[1
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Hematol, NL-1081 HV Amsterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷 / 12期

关键词：

indoleamine 2,3-dioxygenase; INDO; acute myeloid leukemia; immunesurveillance; immune-therapy;

D O I：

10.3324/haematol.13113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Indoleamine 2,3-dioxygenase degrades the amino acid tryptophan which is essential for T cells. Tryptophan depletion causes T-cell cycle arrest and solid tumors that express high levels of indoleamine 2,3-dioxygenase can create immune suppression. Recently, blasts of patients with acute myeloid leukemia were shown to express indoleamine 2,3-dioxygenase. We determined INDO (encoding gene for indoleamine 2,3-dioxygenase) mRNA expression in leukemic blasts of 286 patients with acute myeloid leukemia by gene-expression profiling. Results were validated by quantitative polymerase chain reaction analysis in blasts of an independent cohort of 71 patients. High INDO expression was correlated to significantly shortened overall and relapse-free survival. Correlation of INDO expression to relevant known prognostic factors and survival identified high INDO expression as a strong negative independent predicting variable for overall and relapse-free survival. Inhibition of indoleamine 2,3-dioxygenase expressed by myeloid leukemic blasts may result in breaking immune tolerance and offers new therapeutic options for patients with acute myeloid leukemia.

引用

页码：1894 / 1898

页数：5

共 18 条

[1] PROPOSED REVISED CRITERIA FOR THE CLASSIFICATION OF ACUTE MYELOID-LEUKEMIA - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (04) :620-625

[2] Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells [J].

Brandacher, G ;

Perathoner, A ;

Ladurner, R ;

Schneeberger, S ;

Obrist, P ;

Winkler, C ;

Werner, ER ;

Werner-Felmayer, G ;

Weiss, HG ;

Göbel, G ;

Margreiter, R ;

Königsrainer, A ;

Fuchs, D ;

Amberger, A .

CLINICAL CANCER RESEARCH, 2006, 12 (04) :1144-1151

[3] Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase [J].

Curti, A. ;

Aluigi, M. ;

Pandolfi, S. ;

Ferri, E. ;

Isidori, A. ;

Salvestrini, V. ;

Durelli, I. ;

Horenstein, A. L. ;

Fiore, F. ;

Massaia, M. ;

Piccioli, M. ;

Pileri, S. A. ;

Zavatto, E. ;

D'Addio, A. ;

Baccarani, M. ;

Lemoli, R. M. .

LEUKEMIA, 2007, 21 (02) :353-355

[4] Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells [J].

Curti, Antonio ;

Pandolfi, Simona ;

Valzasina, Barbara ;

Aluigi, Michela ;

Isidori, Alessandro ;

Ferri, Elisa ;

Salvestrini, Valentina ;

Bonanno, Giuseppina ;

Rutella, Sergio ;

Durelli, Ilaria ;

Horenstein, Alberto L. ;

Fiore, Francesca ;

Massaia, Massimo ;

Colombo, Mario P. ;

Baccarani, Michele ;

Lemoli, Roberto M. .

BLOOD, 2007, 109 (07) :2871-2877

[5] Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? [J].

Dallas, PB ;

Gottardo, NG ;

Firth, MJ ;

Beesley, AH ;

Hoffmann, K ;

Terry, PA ;

Freitas, JR ;

Boag, JM ;

Cummings, AJ ;

Kees, UR .

BMC GENOMICS, 2005, 6 (1)

[6] T cell apoptosis by tryptophan catabolism [J].

Fallarino, I ;

Grohmann, U ;

Vacca, C ;

Bianchi, R ;

Orabona, C ;

Spreca, A ;

Fioretti, MC ;

Puccetti, P .

CELL DEATH AND DIFFERENTIATION, 2002, 9 (10) :1069-1077

[7] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].

Gabert, J ;

Beillard, E ;

van der Velden, VHJ ;

Bi, W ;

Grimwade, D ;

Pallisgaard, N ;

Barbany, G ;

Cazzaniga, G ;

Cayuela, JM ;

Cavé, H ;

Pane, F ;

Aerts, JLE ;

De Micheli, D ;

Thirion, X ;

Pradel, V ;

González, M ;

Viehmann, S ;

Malec, M ;

Saglio, G ;

van Dongen, JJM .

LEUKEMIA, 2003, 17 (12) :2318-2357

[8] Immune suppression in the tumor microenvironment [J].

Gajewski, TF ;

Meng, Y ;

Harlin, H .

JOURNAL OF IMMUNOTHERAPY, 2006, 29 (03) :233-240

[9] Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses [J].

Hou, De-Yan ;

Muller, Alexander J. ;

Sharma, Madhav D. ;

DuHadaway, James ;

Banerjee, Tinku ;

Johnson, Maribeth ;

Mellor, Andrew L. ;

Prendergasts, George C. ;

Munn, David H. .

CANCER RESEARCH, 2007, 67 (02) :792-801

[10] Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer [J].

Ino, K. ;

Yoshida, N. ;

Kajiyama, H. ;

Shibata, K. ;

Yamamoto, E. ;

Kidokoro, K. ;

Takahashi, N. ;

Terauchi, M. ;

Nawa, A. ;

Nomura, S. ;

Nagasaka, T. ;

Takikawa, O. ;

Kikkawa, F. .

BRITISH JOURNAL OF CANCER, 2006, 95 (11) :1555-1561

← 1 2 →